Tenet Board Adds Two New Independent Directors
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/20/2026
- Wall Street gains as healthcare stocks rally, oil prices fall
- Brent slips in choppy session as investors weigh attacks on ships, Saudi energy
- Loop Capital downgrades Apple, sees no recovery of cut iPhone shipments
- Wells Fargo says S&P 500 buy signal emerges as investors turn excessively bearish
- ByteDance, Alibaba and Tencent order $35 billion of Nvidia chips: Reuters
- Cerebras Systems falls as TD Cowen cuts price target
- Nasdaq climbs as chip and AI-linked stocks bounce back
- Flutter Entertainment to cut up to 1,400 jobs amid UK tax increases
- 3M issues warrant to Amazon in $6B data center product deal
- Glass House Brands posts Q3 revenue of $56.8M, board member exits
UBS Reiterates Buy on Tenet Healthcare (THC) After Hosting Management Meetings
January 21, 2016 11:23 AM ESTUBS maintained a Buy rating on Tenet Healthcare (NYSE: THC), and cut the price target to $51.00 (from $62.00), after meeting with management. THC reiterated that it expects to show solid growth in 2016 relative to its pro-forma 2015 EBITDA run rate of $2.3 bln. Consensus expectations call for just under $2.5... More
Mizuho Securities Upgrades Tenet Healthcare (THC) to Outperform
January 19, 2016 8:48 AM ESTMizuho Securities upgraded Tenet Healthcare (NYSE: THC) from Neutral to Outperform with a price target of $30.00 as two Glenview partners join the board.
Analyst Sheryl R. Skolnick commented, "Glenview's two HC partners are joining THC's Board and the firm can also appoint... More



